
Daewoong signs $53.6 mil. BTX export deal with Thai partner
Daewoong Pharmaceutical has signed a 73.8 billion won ($53.6 million) export agreement with Thailand’s Montana Marketing for its type A botulinum toxin (BTX) Nabota, marketed as Jeuveau in the U.S. The five-year contract is approximately three times larger …